A Phase 1 Study of [225Ac]-FPI-1434 Injection
Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc.
Tempus AI
Incyte Corporation
Pfizer
Numab Therapeutics AG
NuCana plc
Aminex Therapeutics, Inc.
Fate Therapeutics
Incyte Corporation
CureOne
Novartis
Calando Pharmaceuticals